Vital Chemtech Limited: AGM approves all 7 resolutions with strong shareholder support
Vital Chemtech Limited's 5th AGM on September 28, 2026, saw all 7 resolutions passed unanimously. Key approvals included financial statements for FY26, director re-appointments, auditor ratifications, and related party transactions. Voting concluded with 74.88% of shares polled.
The AGM results confirm the company's operational and governance decisions, which are important for ongoing business and investor relations. The re-appointment of key management and approval of financial statements are routine yet significant.
All resolutions were passed with unanimous support, indicating strong shareholder confidence and approval of the company's decisions.
Vital Chemtech Limited announced the results of the e-voting conducted at its 5th Annual General Meeting (AGM) held on Monday, September 28, 2026. All seven resolutions presented to the shareholders were passed with overwhelming support.
The resolutions included the adoption of the Audited Standalone and Consolidated Financial Statements for the Financial Year ended March 31, 2026, the re-appointment of Mr. Jay Vipul Bhatt as a director, ratification of remuneration for the Cost Auditor and Secretarial Auditor, approval of material related party transactions with Vital Synthesis Limited, and the re-appointment of Mr. Vipul Bhatt as Chairman and Managing Director, along with Mr. Jay Bhatt as Whole-time Director.
The AGM was conducted through Video Conferencing (VC) facility, in compliance with the circulars issued by the Ministry of Corporate Affairs. The record date for voting was September 21, 2026. The total votes polled represented 74.8797% of the outstanding shares. All resolutions received 100% of the votes in favour from the votes polled, with no votes against.
What to do with a filing like this
Vital Chemtech Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vital Chemtech Limited. Read the original for the full detail.